InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by MANZO MICHAEL P., Vice-Président de l'Ingénierie. Officer active across 1 companies, notably Eyegate Pharmaceuticals INC. Aggregated, 8 disclosures have been logged. The latest transaction was disclosed on 3 August 2021 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
€13165 shares@ €2.0227.7% of flow
Common Stock
SEC:0001104659-21-100199·
€13165 shares@ €2.0223.8% of flow
Common Stock
SEC:0001104659-21-100199:0·
€500160 shares@ €3.123429.2% of flow
Common Stock
SEC:0001104659-21-089446·
€500160 shares@ €3.123414.6% of flow
Common Stock
SEC:0001104659-21-089446:0·
€535155 shares@ €3.453431.3% of flow
Common Stock
SEC:0001104659-21-077764·
€535155 shares@ €3.453415.7% of flow
Common Stock
SEC:0001104659-21-077764:0·
€543158 shares@ €3.437431.8% of flow
Common Stock
SEC:0001104659-21-061948·
€543158 shares@ €3.437415.9% of flow
Common Stock
SEC:0001104659-21-061948:0·
8 of 8 declarations
About MANZO MICHAEL P.
Michael P. Manzo is the Vice President of Engineering at Eyegate Pharmaceuticals Inc. He is responsible for leading engineering and research and development teams. His technical expertise and project management experience are essential for developing new therapeutic solutions within the company.
